Rempart Asset Management Inc. Has $20.89 Million Stock Position in Colgate-Palmolive Company $CL

Rempart Asset Management Inc. lifted its position in Colgate-Palmolive Company (NYSE:CL) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 264,418 shares of the company’s stock after buying an additional 8,445 shares during the period. Colgate-Palmolive comprises 3.9% of Rempart Asset Management Inc.’s holdings, making the stock its 13th largest position. Rempart Asset Management Inc.’s holdings in Colgate-Palmolive were worth $20,894,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. CVA Family Office LLC raised its position in shares of Colgate-Palmolive by 8.9% during the fourth quarter. CVA Family Office LLC now owns 3,193 shares of the company’s stock worth $252,000 after purchasing an additional 261 shares during the period. Sax Wealth Advisors LLC grew its position in shares of Colgate-Palmolive by 7.0% in the 4th quarter. Sax Wealth Advisors LLC now owns 20,039 shares of the company’s stock valued at $1,583,000 after purchasing an additional 1,313 shares during the period. Czech National Bank increased its stake in Colgate-Palmolive by 3.5% during the 4th quarter. Czech National Bank now owns 212,548 shares of the company’s stock worth $16,796,000 after purchasing an additional 7,276 shares in the last quarter. Optivise Advisory Services LLC increased its stake in Colgate-Palmolive by 8.7% during the 4th quarter. Optivise Advisory Services LLC now owns 2,958 shares of the company’s stock worth $234,000 after purchasing an additional 236 shares in the last quarter. Finally, Foster Group Inc. raised its holdings in Colgate-Palmolive by 8.0% during the 4th quarter. Foster Group Inc. now owns 3,541 shares of the company’s stock worth $280,000 after buying an additional 262 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CL. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. UBS Group boosted their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. Evercore upped their target price on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, February 2nd. Finally, Citigroup lifted their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Price Performance

NYSE CL opened at $85.35 on Thursday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a market capitalization of $68.80 billion, a PE ratio of 32.58, a price-to-earnings-growth ratio of 3.79 and a beta of 0.28. The firm’s 50 day moving average is $91.12 and its 200-day moving average is $83.37.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.91 earnings per share. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insider Buying and Selling

In related news, COO Panagiotis Tsourapas sold 35,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. This represents a 77.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock worth $17,486,693 over the last 90 days. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.